x
Filter:
Filters applied
- IASLC Staging Articles
- Rami-Porta, RamonRemove Rami-Porta, Ramon filter
- PrognosisRemove Prognosis filter
Publication Date
Please choose a date range between 2013 and 2022.
IASLC Staging Articles
2 Results
- Original Article Translational Oncology
The International Association for the Study of Lung Cancer Staging Project: Methods and Guiding Principles for the Development of the Ninth Edition TNM Classification
Journal of Thoracic OncologyVol. 17Issue 6p806–815Published online: March 9, 2022- Frank C. Detterbeck
- Katherine K. Nishimura
- Vanessa J. Cilento
- Meredith Giuliani
- Mirella Marino
- Raymond U. Osarogiagbon
- and others
Cited in Scopus: 1Stage classification provides a consistent and concise nomenclature about the anatomic extent of the cancer. This is a fundamental cornerstone in the management of patients; it enables reporting results and facilitates comparing one treatment to another and judging how closely clinical trial results apply to an individual patient. A nomenclature must be relatively static; however, periodical refinement is needed to adjust to a changing landscape of clinical relevance. Changes must be well justified and thoughtfully developed to maintain the ability to communicate clearly and facilitate comparisons across time. - Original ArticlesOpen Archive
Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the Staging Project Database of the International Association for the Study of Lung Cancer
Journal of Thoracic OncologyVol. 8Issue 3p315–321Published in issue: March, 2013- David Ball
- Alan Mitchell
- Dori Giroux
- Ramon Rami-Porta
- and The IASLC Staging Committee and Participating Institutions
Cited in Scopus: 46Analysis of the International Association for the Study of Lung Cancer database revealed that for patients with completely resected, node-negative, non–small-cell lung cancer (NSCLC), increasing tumor size was associated with worsening survival. This analysis was performed to determine the effect of size on prognosis in patients in the same database but who were treated with radiotherapy or chemoradiotherapy.